Figure 7.
Validation of expression of the 6 potential biomarkers for the prognosis of SCLC in the LCE database. The forest plot presented the results of survival meta-analyses. (A) MCM2 was a risk factor in lung cancer (HR=1.20, 95% CI: 1.12–1.29). (B) EZH2 was a risk factor in lung cancer (HR=1.17, 95% CI: 1.08–1.27). (C) CDKN2A was a risk factor in lung cancer (HR=1.09, 95% CI: 1.03–1.16). (D) CENPK was a risk factor in lung cancer (HR=1.23, 95% CI: 1.11–1.38). (E) CHEK1 was a risk factor in lung cancer (HR=1.23, 95% CI: 1.14–1.33). (F) EXOSC2 was a risk factor in lung cancer (HR=1.09, 95% CI: 1.02–1.16). TE – log (HR); seTE – SE (log (HR)). (LCE database (http://lce.biohpc.swmed.edu/lungcancer/), meta-analyses module).